Research shows the p-tau217 blood test can indicate very high risk of Alzheimer's disease before symptoms begin, offering ...

A new study reveals that obesity accelerated Alzheimer's blood biomarkers by 95% over five years, highlighting a strong ...

A new study suggests the shingles vaccine may lower the likelihood of developing dementia as well as slow its progression in ...

Early Alzheimer's patients who completed their course of donanemab therapy by 12 months had cognitive and functional benefits lasting for 2 additional years, reported Jennifer Zimmer, MD, of Eli Lilly ...

High levels of calcium are toxic to cells and contribute to loss of neurons in Alzheimer's disease. A new study published in ...

In people at risk for Alzheimer’s disease, researchers linked minimal to moderate physical activity to a 3-to 7-year delay in cognitive symptoms.

Japan, a country with over one-third of its people aged above 65 years, is reeling under a severe dementia crisis. Dementia ...

New findings show that removing Centaurin-α1, a protein elevated in Alzheimer’s disease, significantly reduces inflammation, plaque buildup, and cognitive deficits in a well-established mouse model.

Alzheimer’s disease accounts for most of the cases of dementia, a condition characterized by progressive or persistent loss ...

Scientists are finding that brain immune cells known as microglia with a specific mutation (at right) stayed young and ...

Researchers have conducted the first study evaluating the impact of obesity on Alzheimer's disease blood biomarkers (BBMs).

A large quasi-experimental study in Wales shows that eligibility for shingles vaccination is linked to fewer new mild ...